6856-27-5 (醋酸炔诺酮杂质F(EP) 标准品,6b-Hydroxy Norethindrone Acetate)

4-(二溴甲基)-2,1,3-苯并噻二唑;6beta-羟基炔诺酮乙酸酯;6-Β羟基醋酸炔诺酮;6-β-羟基醋酸炔诺酮(醋炔诺酮杂质F);醋酸炔诺酮杂质F(EP) 标准品;

6β-Hydroxy Norethindrone Acetate;[(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;6beta-Hydroxy Norethindrone Acetate;6856-27-5;A-Hydroxy Norethindrone Acetate;6?-Hydroxy Norethindrone Acetate;AKOS032958248;19-NOrpregn-4-en-20-yn-3-one, 17-(acetyloxy)-6-hydroxy-, (6;6beta-Hydroxy-3-oxo-19-nor-17alpha-pregn-4-en-20-yn-17-yl Acetate (6beta-Hydroxynorethisterone Acetate);A)-;Norethisterone Acetate Imp. F (EP); 6beta-Hydroxy-3-oxo-19-nor-17alpha-pregn-4-en-20-yn-17-yl Acetate; 6beta-Hydroxynorethisterone Acetate; Norethisterone Acetate Impurity F;WJX543VUS5;NORETHISTERONE ACETATE IMPURITY F [EP IMPURITY];6;A,17;19-NORPREGN-4-EN-20-YN-3-ONE, 17-(ACETYLOXY)-6-HYDROXY-, (6.BETA.,17.ALPHA.)-;DTXSID50462114;6.BETA.-HYDROXYNORETHINDRONE ACETATE;SCHEMBL5722719;6ss-Hydroxynorethindrone acetate;6b-Hydroxy Norethindrone Acetate;

NVEXGWVOAPQSMX-VIHHZYQKSA-N

1S/C22H28O4/c1-4-22(26-13(2)23)10-8-19-17-12-20(25)18-11-14(24)5-6-15(18)16(17)7-9-21(19,22)3/h1,11,15-17,19-20,25H,5-10,12H2,2-3H3/t15-,16-,17-,19+,20-,21+,22+/m1/s1

O(C(C)=O)[C@@]1(C#C)CC[C@H]2[C@@H]3C[C@H](C4=CC(CC[C@@H]4[C@H]3CC[C@@]21C)=O)O